We describe a novel method for assessing the "open" or "closed" state of chromatin at selected locations within the genome. This method combines the use of Benzonase, which can digest DNA in the presence of actin, with quantitative polymerase chain reaction to define digested regions. We demonstrate the application of this method in brain homogenates and laser captured cells. We also demonstrate application to selected sites within more than 1 gene and multiple sites within 1 gene. We demonstrate the validity of the method by treating cells with valproate, known to render chromatin more permissive, and by comparison with classical digestion with DNase I in an in vitro preparation. Although we demonstrate the use of this method in brain tissue, we also recognize its applicability to other tissue types.
Introduction
The epigenetic regulation of chromatin structure is a major component of the gene expression regulatory machinery, and this regulation is accomplished by multiple mechanisms including DNA methylation and hydroxymethylation, multiple histone modifications, binding molecules, and complex interactions among all these elements (Jaenisch and Bird, 2003; Mastroeni et al., 2011; Chouliaras et al., 2013) . These complex interactions converge to modulate chromatin structure, much as multiple inputs converge on the final common path of the anterior horn cells (Sherrington, 1906) . By analogy, we posit chromatin structure as the final common path of multiple epigenetic mechanisms.
Chromatin structure determines whether any selected segment of DNA is accessible to transcription factors, DNA binding proteins, or other modifiers which govern a gene's availability for transcription (Quina et al., 2006) . There are multiple classes of methods for examining chromatin structure. Broadly speaking, these are methods that use DNase I digestion, chromatin precipitation, matrix-assisted reader chromatin capture, and others, which are typically followed by methods to determine location of permissive or repressive chromatin structure.
In the past, permissive, or open, chromatin has been identified by DNase I nuclease sensitivity analysis (Krebs and Peterson, 2000) , and more recently, open chromatin data generated from DNase-seq have been able to predict cell-type-specific gene expression (Natarajan et al., 2012) .
An overview of current methods available to ascertain chromatin structure yields a broad range of approaches, many of which are variations of chromatin immunoprecipitation (ChIP), an antibodybased methodology first described by Lis (1984, 1985) . Fast carrier ChIP (Fast CChIP) can be used to study transcription factor binding in small amounts of fresh tissue (Hao et al., 2008) . Another ChIP-based technique uses genomewide chromatin immunoprecipitation in concert with tiling microarrays (ChIP-chip). ChIP-chip, along with ChIP-quantitative polymerase chain reaction (qPCR), showed that transcription factor FoxA1 is differentially recruited to cell-typespecific enhancers (Lupien et al., 2008) . ChIA-PET combines ChIP with paired-end DNA sequencing to determine global de novo chromatin interactions (Fullwood et al., 2009) . PAT-ChIP, also a ChIP-directed technique, was used to isolate, extract, and sequence chromatin from formalin-fixed, paraffin-embedded tissue samples (Fanelli et al., 2010; Fanelli et al., 2011; Amatori et al., 2014) . A common method used to determine chromatin structure is DNase I digestion of DNA with subsequent sequencing of resulting fragments (DNase-seq).
The sites of cleavage are called DNase I hypersensitive sites (DHSs), suggesting areas of the chromatin accessible to DNase digestion to be "open" and poised for transcription. A recent international epigenetic collaborative study, Encyclopedia of DNA Elements (ENCODE), created a genomewide map of DHSs in 125 human cell lines and tissue types and correlated those sites with ChIP-seq data (Thurman et al., 2012) . In addition to genomewide mapping of DHS, DNase I sensitivity and sequencing can be used to analyze receptor binding influences on chromatin structure at specific gene loci in vitro (Tewari, et al., 2012) . More recently, a modification to ChIP-Seq, called Bar-ChIP, allowed multiple DNA-protein interactions to be simultaneously profiled by attaching molecular barcodes to chromatin fragments from Saccharomyces cerevisiae (Chabbert et al., 2015) .
Chromosome conformation capture (3C) technologies have been used for more than a decade. First described in Dekker et al. (2002) , 3C delivers 3-dimensional chromatin structure information based on interaction frequencies between genomic loci. Some 3C technologies, such as e4C, use ChIP within the protocol (Sexton et al., 2012) . Capture-C, the most recent derivative of the 3C technique, modifies the 3C method into a multiplexed, high-throughput approach to analyzing cis-acting elements that control gene expression (Hughes et al., 2014) .
A ChIP-less technique to examine the epigenome, called MARCC (matrix-assisted reader chromatin capture), is a platform that probes combinatorial histone modification patterns to determine functional chromatin conformation (Su et al., 2014) . Finally, direct chromatin PCR is a method for gene-specific chromatin analysis performed on cultured cells using properties of standard PCR buffers and thermal cycling temperatures to amplify open regions of chromatin (Vatolin, et al., 2012) .
Although ChIP and non-ChIP-based techniques have been broadly used in elucidating chromatin structure and its impact on gene regulation, caveats to their use exist. The ChIP-based techniques rely on antibodies, which involve problems with antibody specificity and optimization (Orlando, 2000) . Moreover, most ChIP and non-ChIPbased methods need large amounts of cultured cells or fresh tissue to start with. In addition, these complicated protocols take several days to complete and can be expensive with labor, reagents, equipment, and per-sample core costs (Sheffield and Furey, 2012) .
A major limitation of DNase I-based methods is the susceptibility of DNase I to inhibition by actin, a component of many cells and tissues. Recently, a protocol was developed for determining chromatin accessibility in frozen tissue homogenates using Benzonase, a robust nuclease whose efficacy is not affected by the presence of actin (Grøntved et al., 2012) . Here we describe a protocol to assess chromatin structure at specific loci using Benzonase digestion and qPCR of DNA extracted from frozen tissue homogenates and laser capture dissected defined cells. This protocol is relatively quick, inexpensive, and achievable in any research laboratory outfitted with standard real-time PCR equipment. This novel method will allow a more focused examination of chromatin structure, its influence on gene expression, and the impact it may have on gene expression in normal and diseased brain as well as other tissues.
Materials and methods

Tissue (samples)
All frozen brain tissue samples and frozen brain sections were obtained from the Brain Bank at Banner Sun Health Research Institute. Average postmortem delay at this Brain Bank is 2.6 hours. Homogenate studies used approximately 1 g of middle temporal gyrus (MTG) and cerebellum (CBL) from each of 3 nondemented controls (NDs) and 3 Alzheimer's disease (AD) cases. Laser capture microdissection (LCM) studies used 10-μm serial sections of MTG (area 22) from 1 ND and 1 AD case and 10-μm serial sections of hippocampus from 5 ND and 5 AD cases.
Primers
Primer design for chromatin accessibility analysis
Primers for KAT6B, APP, and RSP28 were designed to cover the area 300 base pairs (bp) upstream of the transcription start site and 100 bp downstream of the transcription start site. The primer sequences for GAPDH, CTCF4, and CTCF10 were taken from He et al. (2014) and chosen to represent areas of the genome known to be constitutively open (GAPDH) and/or uniform in openness across sample types (CTCF4, CTCF10) (Li et al., 2013) . All primers were checked for specificity via the National Center for Biotechnology Information's BLAST search.
To examine chromatin structure in multiple regions of 1 gene, primers for ARC were designed based on ENCODE data (Thurman et al., 2012) . ARC1 was located in the promoter region, an area identified with high significance as open chromatin and validated by DNase I hypersensitivity and formaldehyde-assisted isolation of regulatory elements (FAIRE) assays. This area contained DNase I hypersensitivity in 113 of 125 cell lines/types. Transcription factor ChIP-seq data show it to be densely populated with DNA binding proteins (transcription factors, transcription machinery components, chromatin factors) with varying degrees of occupancy. ARC2 was located adjacent to ARC1, breaching the start of the coding sequence. This area was validated by both DNase I hypersensitivity and FAIRE assays with DNase I hypersensitivity in 16 of 125 cell lines/types. ChIP-seq data identified several DNA binding proteins with varying degrees of occupancy. ARC3 was located near the end of the gene in the third exon. This area contained DNase I hypersensitivity in 10 of 125 cell lines/types. This region was considered high significance as open chromatin but not validated by both DNase I and FAIRE assays. Transcription factor CTCF occupancy is shown to be weak. ARC4 was designed in an area that could be considered a "control," an intronic region between exons 2 and 3.
To determine the optimal annealing/extension temperatures for all primer sets designed, a gradient PCR with melting curve was run. Based on the results of the gradient, a standard curve PCR was performed to test the PCR efficiency. Efficiency greater than 90% was acceptable. After optimizing PCR protocols, the samples were run within those parameters. Primer sequences are found in Table 1. 2.3. Brain homogenates 2.3.1. Benzonase digestion (adapted from Grøntved et al., 2012) Approximately 600 mg of frozen brain tissue was pulverized with a mortar and pestle that had been prechilled on dry ice. The pulverized tissue was transferred to a prechilled 15-mL tube and then suspended in 4 mL of lysis buffer (30 mmol/L Tris-HCL [pH 8.0], 2 mmol/L EDTA, 2 mmol/L EGTA, 20 mmol/L sodium butyrate, 2 mmol/L sodium orthovanadate, 4 mmol/L sodium fluoride, protease Table 1 Primer sequences used for qPCR to determine chromatin accessibility
Gene
Forward Reverse   KAT6B CCCCAATGGGCTGCAGAGTGGTTAG CGCTGCCGCTGCCTGAGAAACT  APP  CTCCCACTGTTCACGAAGCCCAGGT  CTACCGCTGCCGAGGAAACTGACG  ARC1  GGGCCTCGCTGGCTGCATAAAGAG  GTCCGGTGGTCCAGCTCCATCTGT  ARC2  ACTCGCAGCGCTGGAAGAAGTCCAT GCGTAGGGGCTGACGGTGTAGTCGT  ARC3  TGGTCCTTCACTGCCCACTCTCCTG  CTAAGCTGGGGCTCCTGCCCTCTG  ARC4  ATGAGCTCCTCCCCAGACCCCAGAC  GCAGTGAAGGACCACGCAGGACAGT  RPS28 AGAGCGAAGGGTCCCGGCTTAGGAG AGAGGAGTCACGTGCTTCGGGGAGA  GAPDH AAAAGCGGGGAGAAAGTAGG  AGAGGAGTCACGTGCTTCGGGGAGA  CTCF4  CCCCAGAGAGTAGGGAACAG  GGCACGCAAAGACATACTGA  CTCF10 AGAGCACCCCCTACTGGCTAA  TAAGAAGCTGTGCGCGATGAC inhibitor cocktail [Pierce]) using a syringe fitted with a 20-gauge needle. Volume was brought up to 6 mL with lysis buffer. Using a 23-gauge needle, the suspension was mixed and distributed in 500-μL equal-volume aliquots into 2-mL microfuge tubes and incubated on ice for 5 minutes. Aliquots not needed were frozen at 20°C for later use. To the aliquots being used, 500 μL of nuclease digestion buffer (30 mmol/L Tris-HCL [pH 8.0], 14 mmol/L MgCl 2 , 0.5% NP-40, 0.2% fatty acid-free bovine serum albumin, 0.25 U/μL Benzonase [EMD Millipore]) was added. A no-nuclease control sample was also prepared. The tubes were gently inverted to mix and incubated at 37°C for 3 minutes. Immediately after the incubation, EDTA (at 50-mmol/L final concentration) and sodium dodecyl sulfate (SDS) (at 0.1% final concentration) were added to stop the digestion reaction. Fifty microliters of RNaseA/RNaseT1 (Ambion/Life Technologies) was added and incubated overnight at 45°C. After incubation, SDS was added to final concentration of 0.75% and placed at 45°C for 2 hours. Proteinase K (Sigma) was then added to final concentration of 0.8 μg/mL and incubated overnight at 45°C. Digested and undigested DNA reactions were purified by gel extraction (Wizard SV Gel and PCR Clean Up, Promega) or phenol chloroform extraction and ethanol precipitation and then quantified with Quant-iT PicoGreen Assay (Life Technologies).
Chromatin accessibility analysis by qPCR (adapted from Rao et al., 2001)
Five nanograms of digested and undigested DNA from each sample was amplified in triplicate for 50 cycles on an iCycler iQ (Bio-Rad) using EpiQ SYBR Green Supermix (Bio-Rad) (This supermix was discontinued in early stages of protocol design. iTaq Universal SYBR Green Supermix [Bio-Rad] was used for remaining experiments.) and 2-μmol/L primers under the optimized parameters for each primer set. In the resulting PCR analyses, higher C T values indicate more "open" chromatin accessible to regulatory elements.
Laser capture microdissected derived cells
Benzonase digestion of many cells
Ten-micrometer frozen sections of hippocampus from (5) AD and (5) ND cases were mounted on PEN slides (Leica) and kept under desiccant at − 80°C until use. After a brief thaw, sections were placed in 100% EtOH then 95% EtOH and a final 70% ethanol for 5 seconds each then rinsed with molecular grade water. Neutral red stain (1%) was applied for 30 seconds and then rinsed twice with molecular grade water and dehydrated for 5 seconds in 70% EtOH then 95% EtOH and for 1 minute in 100% ethanol. Laser capture microdissection of dentate gyrus granule cells was performed on an LMD 6500 (Leica). Briefly, 40 μL of lysis buffer (20 mmol/L Tris-HCL [pH 7.5], 2 mmol/L EDTA, 1 mmol/L EGTA, 0.5% glycerol, 20 mmol/L sodium butyrate, 2 mmol/L sodium orthovanadate, 4 mmol/L sodium fluoride, protease inhibitor cocktail [Pierce]) was added to the cap of the tube where the sample was captured. After a 1-minute spin, another 40 μL of lysis buffer was added to the cap. The tube was set upside down on a bench for 20 minutes, spun down in a bench top centrifuge for 1 minute, and then split equally (40 μL) into 2 tubes for no-enzyme control and enzyme digestion. For enzyme digestion, 40-μL nuclease digestion buffer (40 mmol/L Tris-HCL [pH 8.0], 6 mmol/L MgCl 2 , 0.3% NP-40, 1% glycerol, 0.25 U/μL Benzonase [EMD Millipore]) was added. The no-nuclease control tube received 40 μL of nuclease digestion buffer minus the Benzonase. Both tubes were placed at 37°C for 2.5 minutes. To stop the reaction, EDTA (10 mmol/L final) and SDS (0.75% final) were added to each tube. Then, 4 μL RNaseA/RNase T1 was added, and the tubes were placed at 45°C overnight. The next day, SDS at 0.75% final concentration was added and incubated for 2 hours at 45°C. Next, Proteinase K (0.5 μg/mL final) was added and incubated overnight at 45°C. The digested and undigested DNA reactions were purified by phenol chloroform extraction and ethanol precipitation.
Chromatin accessibility analysis by qPCR of many cells (dentate gyrus granule cells)
Digested and undigested DNA from each sample was amplified in duplicate for 50 cycles on an iCycler iQ (Bio-Rad) using iTaq Universal SYBR Green Supermix (Bio-Rad) and 2-μmol/L primers under the optimized parameters for each primer set.
Benzonase digestion of few cells
Ten-micrometer frozen serial sections of MTG from (1) AD and (1) ND case were mounted on PEN slides (Leica) and kept under desiccant at − 80°C until use. After brief thaw, sections were stained with 1% neutral red to identify pyramidal neurons. Neurofibrillary tanglebearing neurons were identified by staining an adjacent section with 0.1% Thioflavin S for 15 seconds. Non-tangle-bearing pyramidal neurons were chosen after comparing the adjacent sections and excluding tangle-bearing cells. To stop the reaction, EDTA (10 mmol/L final) and SDS (0.75% final) were added to each tube. Then, 1.5 μL RNaseA/RNase T1 was added, and the tubes were placed at 45°C overnight. The next day, SDS at 0.75% final concentration was added and incubated for 2 hours at 45°C. Next, Proteinase K (0.5 μg/mL final) was added and incubated overnight at 45°C. The digested and undigested DNA reactions were purified by phenol chloroform extraction and ethanol precipitation.
Chromatin accessibility analysis by qPCR of few cells (non-tangle-bearing neurons)
Approximate equivalents of 5 cells underwent qPCR on an iCycler iQ (Bio-Rad) with the same APP primers and conditions as with frozen homogenates protocol except that the cycle number was extended to 80 cycles because of the minute amount of starting material. A 1.5% agarose gel was run to verify amplification of 260-bp amplicon (data not shown). 5 cells/mL in 6-well plates. Two days later, they were fed with complete DMEM, and half the wells were treated with 1 mmol/L valproic acid (VPA) (Sigma), an HDAC inhibitor known to decondense chromatin (Felisbino et al., 2011; Felisbino et al., 2014) , and half were left untreated. After incubating for 24 hours at 37°C and 5% CO 2 , they were washed twice in 1 × phosphate-buffered saline, collected by centrifugation, washed twice in ice-cold wash buffer (20 mmol/L Benzonase was added to appropriate tubes for a final concentration of 0.5 U/mL. Tubes were incubated at 37°C for 3 minutes. To stop the reaction, EDTA (10 mmol/L final) and SDS (0.75% final) were added to each tube. Next, Proteinase K (0.5 μg/mL final) was added and incubated overnight at 45°C. The digested and undigested DNA reactions were purified by phenol chloroform extraction and ethanol precipitation and quantified by Quant-iT PicoGreen Assay (Life Technologies). Digested and undigested DNA (5 ng) from each sample was amplified in duplicate on an iCycler iQ (Bio-Rad) using iTaq Universal SYBR Green Supermix (Bio-Rad) and 2-μmol/L primers as per the optimized parameters determined by gradient and melting curve PCR.
Validation in vitro by
Validation in vitro by comparison of Benzonase with DNase I digestion in SH-SY5Y cells
SH-SY5Y cells were cultured and maintained as described above. Tubes were incubated at 37°C for 11 minutes. To stop the reaction, 160 μL of 50 mmol/L EDTA was added, and tubes were inverted 5 times to mix. The digested and undigested DNA reactions were purified by phenol chloroform extraction and ethanol precipitation and quantified by Quant-iT PicoGreen Assay (Life Technologies). Digested and undigested DNA (5 ng) from each sample was amplified in duplicate on an iCycler iQ (Bio-Rad) using iTaq Universal SYBR Green Supermix (Bio-Rad) and 2-μmol/L primers as per the optimized parameters determined by gradient and melting curve PCR.
Results
Homogenate samples
3.1.1. 1 case of AD, promoter region of 2 genes in 2 different brain regions For proof of concept, brain homogenates from MTG and CBL of 1 AD case were digested with Benzonase. The amplification curves of the digested and undigested samples for genes KAT6B and APP demonstrate that undigested DNA has the lowest C T values for both genes and brain regions, and the promoter regions of KAT6B and APP are more open in MTG than CBL (Fig. 1) . APP plays a prominent role in Alzheimer's pathology, and increased expression of KAT6B, a lysine acetyltransferase, has been associated with decreased expression of synaptophysin, a presynaptic molecule. Because the MTG is more affected in AD than is the CBL, it can be expected that the promoter regions of these genes would be more permissive in the MTG, consistent with literature showing CBL to be less affected than MTG in Alzheimer's disease.
More cases and 2 brain regions with comparison of Alzheimer's and control samples
Subsequently, the number of cases was increased to MTG and CBL of 3 ND and 3 AD cases. In MTG, KAT6B and APP were more open in AD than ND (Fig. 2A) . The results also showed that in CBL, KAT6B and APP were more open in AD as compared with ND (Fig. 2B) , suggesting some effect of AD in CBL, although less than in MTG, replicating the conclusion from Fig. 1 that MTG is more affected than CBL (compare relative heights of bars in Fig. 2A, temporal gyrus, and 2B, CBL) . C T values indicate that both genes are more open in MTG ( Fig. 2A ) than in CBL (Fig. 2B) .
More regions within 1 gene-homogenates of MTG
Up to this point, chromatin accessibility analysis was limited to the promoter region of genes. To demonstrate ability to examine multiple regions within 1 gene, primers were designed for 4 regions of the Arc gene. Arc was selected for study because of its role as an immediate early gene important for memory (Guzowski et al., 2000) . Four regions within the Arc sequence were chosen based on DNase I sensitive sites and H 3 K 4 Me 3 ChIP analysis from the ENCODE project (Thurman et al., 2012) . In this brain region, analysis of variance (ANOVA) shows differential relative openness among the 4 arc regions examined (P = 0.01). The promoter region of Arc (ARC1) is significantly less open in AD than in ND (t test P b .05) (Fig. 3) , consistent with the deficient memory function characteristic of Alzheimer's disease.
Laser capture samples
Many dentate gyrus granule cells
To test compatibility of our protocol with LCM, we used a Leica LMD 6500 to dissect a portion of the dentate gyrus granule cell layer followed by Benzonase digestion and qPCR for 4 regions of the ARC gene. Fig. 4 shows representative qPCR traces of the promoter region of ARC from 1 ND and 1 AD case (Fig. 4A) and of an intronic region of ARC in 1 ND and 1 AD case (Fig. 4B) . The C T values of all undigested samples are comparable and lower than digested samples, as expected. ANOVA analysis of the C T values showed no significant difference between primer groups and no significant difference in openness between ND and AD in any of the gene regions (t test) (Fig. 5) . For example, in support of this analysis seen in Fig. 4B , the qPCR traces of ARC4 in digested ND and AD samples show that chromatin appears to be equally accessible. This result differs from the result shown for homogenate data in Fig. 3 . We emphasize that this is a different brain region in which neurons do not typically show the neurofibrillary tangle pathology of Alzheimer's disease and granule cells of the dentate gyrus are not lost in AD (West et al., 1994) .
Few MTG pyramidal neurons
To test the lower limit of the protocol, layer 3 pyramidal neurons from 1 ND and 1 AD case with no tangle pathology were selected in MTG and captured via LCM. Samples equaling 5 cell equivalents were subjected to Benzonase digestion and chromatin accessibility for APP determined by PCR. The data indicate that the promoter region of the APP gene is less open in AD than in NDs (Fig. 6) . A 1% agarose gel indicated PCR products at the appropriate size (data not shown). These data indicate that this protocol can be used on as few as 5 laser captured cells but appear contradictory to the homogenate data. We can theorize as to why the difference in results, from the heterogeneity of cells in homogenates masking the data (Wills et al., 2013) to the minute starting material from single cells confounding the data. Nevertheless, we assert that without additional samples and replicates, we cannot make a determination of chromatin accessibility of APP in ND or AD in non-tangle-bearing neurons of the MTG.
Validation
By treatment known to open chromatin
We treated SH-SY5Y cells with VPA, an HDAC inhibitor known to decondense chromatin (Marchion et al., 2005) . The prediction was that VPA-treated cells would show more open chromatin than cells not treated with VPA. Fig. 7 shows this to be true for the promoter region of KAT6B and APP genes, with equivocal results in the promoter region of Arc (ARC1) (Fig. 7) . The lack of effect that VPA had on Arc could be inherent to SH-SY5Y cells. Past studies found that Arc expression in these cells is a fine-tuned balancing act between translation-dependent mRNA decay and proteasomal degradation, and without specific stimulation, Arc expression is negligible (Soulé et al., 2012) . This leads us to consider that regulation of Arc may not be so dependent on histone acetylation; thus, VPA may not act on the chromatin in the promoter region of Arc the same way as with KAT6B and APP.
The results of the chromatin accessibility analysis showed no difference in relative openness in the no-Benzonase digestion in VPA-treated and untreated cells but large increases in openness in VPA-treated cells digested with Benzonase, as expected (Fig. 7) . In addition, it appeared that the VPA relaxed the chromatin in the primer-specific areas of KAT6B and APP, with a significant difference in relative openness between VPA treated without Benzonase digestion and VPA treated plus Benzonase digestion with Student t test of P b .05 (Fig. 7) .
By comparison with DNase I
To further validate our Benzonase protocol, we compared it with conventional DNase I digestion, the standard method for determining active, or "open," areas of chromatin (Krebs and Peterson, 2000) . To compare Benzonase digestion to DNase I digestion, we analyzed chromatin accessibility in 7 distinct regions of the genome after digesting SH-SY5Y cells with selected concentrations of each enzyme. Comparison of the peaks in the Benzonase-digested cells (Fig. 8A) to those in the DNase I-digested cells (Fig. 8B) showed similar patterns of relative openness, substantiating that the 2 enzymes function comparably. To determine the effect of concentration of DNase I and Benzonase on our data, we converted the data to standard scores. The resulting standard scores are presented in Fig. 8C , which indicates that under the conditions examined and over the concentration ranges used, Benzonase and DNase I act very similarly.
Discussion
We have described a new method for examining chromatin structure that digests DNA with Benzonase to avoid the problems posed by actin when using DNase I. We have demonstrated the application of this method to homogenates of brain tissue, to laser microdissected brain tissue, to small numbers of neurons obtained by LCM, and to in vitro cell preparations. We have demonstrated the applicability of this method to examination of multiple genes as well as multiple sites within 1 gene. We have experimentally demonstrated the validity of our method by treating cells with valproate, a reagent known to render chromatin more permissive, and by comparison with DNase I digestion.
The premise behind our chromatin accessibility analysis using a nuclease and qPCR is that "open" chromatin will be subject to enzyme cleavage; therefore, less available to amplify in qPCR; leading to higher C T values. Meaning, the higher the C T value is, the more accessible the chromatin is for initiation of transcription. Our novel protocol uses Benzonase, a nuclease that can successfully digest chromatin and whose efficacy is not inhibited by actin, as is the case with DNase I (Lazarides and Lindberg, 1974) .
Initial experiments in frozen brain homogenates from 1 AD case demonstrated differential chromatin "openness" between 2 brain regions, as well as between 2 genes of interest. In this case, the promoter region of KAT6B and APP appeared more open in MTG than in CBL. When the number of cases was increased to compare chromatin accessibility between brain regions and disease states, the results showed that defined regions of both genes were more open in AD than ND in both brain regions and that both genes are more open in MTG than CBL, confirming the previous study.
When we tested the lower limits of our protocol on 5 neurons obtained by LCM, we yielded seemingly different results than shown in the homogenates. We can speculate that cell heterogeneity in homogenates can mask the results that we may observe down to single-cell to few-cells level (Wills et al., 2013) . Nevertheless, we emphasize that, without additional samples and replicates, we cannot draw a valid conclusion on chromatin accessibility from our 5 cell data.
We also used our method to examine chromatin structure at multiple sites within 1 gene. ARC was interrogated at 4 sites in MTG homogenate samples. Results showed that the promoter region of the ARC gene was significantly less open in AD than ND. When done on the dentate gyrus of LCM samples, there was no significant difference found in any of the 4 regions of the gene. We stress that this is a (West et al., 1994) or neurofibrillary tangle pathology of Alzheimer's disease. Therefore, the finding of no difference between AD and ND in this region is to be expected.
Validation experiments began with treating SH-SY5Y cell with VPA, an agent known to decondense chromatin (Marchion et al., 2005) . The treatment relaxed the chromatin as expected, validated by showing that the chromatin in VPA-treated cells digested with Benzonase was more open than that in cells not digested. Finally, when comparing chromatin structure (accessibility) in SH-SY5Y cells that had been digested with Benzonase to those digested with DNase I, the criterion standard used for chromatin studies in cultured cells, similar patterns emerged. This concluding validation step demonstrates the efficacy and usefulness of Benzonase for chromatin structure analysis studies.
New methods to determine chromatin accessibility seem to arise at a consistent pace. One of the most recent examines chromatin structure at the single-cell level, however, only in cultured cells (Buenrostro et al., 2015) . Up until now, no method existed to determine chromatin structure in frozen tissue samples at the level of defined cells. The protocol detailed here bridges that gap. This proposed novel method for frozen tissue demonstrates the capability to choose specific cell types to interrogate based on disease versus nondisease, or cells that express a particular protein, cells of a certain morphology, or cells in particular regions of tissue. This potential could translate into the ability to identify specific regulatory mechanisms implicated in disease or normal cellular processes.
Numerous epigenetic mechanisms converge to modulate chromatin structure, and many methods exist to delineate this structure. Most of these methods require considerable amounts of starting material, personnel time, reagent costs, and expensive equipment. The protocol we describe investigates chromatin structure at distinct genomic loci from frozen tissue and defined cells obtained by LCM. In addition, the protocol is rapid, inexpensive, and easily executed in a typical research laboratory setting.
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